Wall Street falls after strong week; Pfizer and Allergan drag
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/5/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
SunTrust Upgrades Pfizer (PFE) to Neutral
November 25, 2015 7:45 AM ESTSunTrust Robinson Humphrey upgraded Pfizer (NYSE: PFE) from Reduce to Neutral with a price target of $37.00.
For an analyst ratings summary and ratings history on Pfizer click here. For more ratings news on Pfizer click here.
Shares of Pfizer closed at $31.97 yesterday.
... MoreSlow Sales Drive 3Q Miss for GameStop (GME); Baird Cuts Price Target to $46
November 23, 2015 3:33 PM ESTBaird maintained an Outperform rating on GameStop (NYSE: GME), and cut the price target to $46.00 (from $54.00), following the company's 3Q earnings report. GME reported revenues and EPS of $2.01B and $0.54, respectively, below consensus expectations of $2.15B and $0.59. The miss was driven by soft next-gen... More
Guggenheim Remains Positive on Mallinckrodt (MNK) Post 4Q Beat
November 23, 2015 10:37 AM ESTGuggenheim maintained a Buy rating and $130.00 price target on Mallinckrodt plc (NYSE: MNK) following the company's 4Q earnings report. MNK reported F4Q15 EPS of $1.84, $0.09 higher than consensus. Management reaffirmed its F'16 EPS guidance of $7.70 to $8.20 compared to consensus of $7.91.
Analyst Louise... More
GameStop (GME) Misses Q3 EPS by 5c; Guides Q4 EPS Below Expectations
November 23, 2015 8:31 AM EST(Updated - November 23, 2015 8:32 AM EST)
GameStop (NYSE: GME) reported Q3 EPS of $0.54, $0.05 worse than the analyst estimate of $0.59. Revenue for the quarter came in at $2.02 billion versus the consensus estimate of $2.15 billion.
Comps fell 1.1 percent.
GameStop reaffirmed FY2015... More

